- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06111092
Testing Design Thinking Methodology to Engage Hispanic and Latino Families of Autistic Children in Research.
The goal of this study is to compare the level of engagement in the Hispanic and Latino parents of autistic children and culturally adapt the protocol of Ayres Sensory Integration to improve participation and health outcomes.
The main questions it aims to answer are:
Does the Design Thinking process result in higher stakeholder engagement and satisfaction in the research process in comparison to Focus Groups? Secondary question: Do cultural adaption using DT data yield higher scores of acceptability and implementation feasibility in comparison to FG methods?
Participants will:
- Be randomized into two groups of engagement (focus groups and design thinking)
- Be blinded (clinicians, selected caregivers, autistic persons, and cultural experts) and will rate the acceptability, feasibility, and cultural appropriateness of the protocol based on DT data higher than the protocol based on FG data.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Racial and ethnic minorities with autistic children experience delays in access to therapy services that can result in poorer outcomes, decreased quality of life, and increased parental and financial stress. Many autism interventions were developed and tested with only White participants, assuming they could be transferable to minority populations. However, research has found that this is not the case and that interventions that are not adapted to an individual's culture and ethnicity do not work as well and are not used as frequently. In this project, we compare two methods of stakeholder engagement, Design Thinking (DT) and Focus Groups (FG), to determine which is better at getting input on the facilitators and barriers to access therapy for autistic children. We focus on Hispanics and Latinos as this is the largest minority group in the US, with one of the fastest-growing groups of autistic children. Our long-term objective is to improve the functional skills and health of Hispanic/Latino autistic children and their families by improving access to an occupational therapy intervention designed to improve daily living skills, socialization, and quality of life. Occupational therapy using Ayres Sensory Integration (OT/ASI) is the only evidence-based intervention that addresses the sensory symptoms in autism. We will use input from these engagement sessions to adapt two versions of the OT/ASI manual: one using DT data and the other using FG data. Outcomes are evaluated following each step. Following the completion of this project, the planned outputs of the study are data on the most effective minority stakeholder engagement method and a culturally adapted OT/ASI manual for Hispanic and Latino autistic children for clinicians and researchers. This information can support future researchers who are engaging Hispanic/Latino individuals or other minority groups in research.
Methods: A randomized mixed methods design is used to evaluate stakeholder engagement methods. Phase one will compare two stakeholder engagement methods (Design Thinking -DT, and Focus Group - FG) and evaluate stakeholder engagement based on the PCORI areas of stakeholder engagement which are operationalized in the Stakeholder-Centric Engagement Evaluation and qualitative data. Phase two utilizes data from phase one to culturally adapt the intervention (two separate intervention protocols will be adapted - one based on FG data and another based on DT data as described below), and obtain stakeholder input on acceptability and feasibility for the Hispanic/Latino autistic population. This provides a second way to measure the effectiveness of each stakeholder engagement method as we will have data to indicate which method (DT or FG) resulted in the highest-rated protocol. The data provided by this study will be used as a basis for a later comparative effectiveness study that will study the culturally adapted protocol's outcomes.
All sessions will be held in Spanish and/or English based on the groups' preferences. Since our intent is to hear the voices of Hispanic/Latino stakeholders, it seems valuable to hold focus groups in Spanish when the participants are Spanish as first language speakers (hereafter referred to as Spanish-first) with audio recordings and later transcription into English for analysis. To accommodate those who prefer English, we will make every effort to group these participants together. When, and if, the Spanish-first groups include participants who prefer English, we will have a Spanish to English translator available. In other words, we will be respectful of each participant's language to optimize their comfort in the engagement sessions.
This project addresses an urgent need to engage stakeholders as part of the research process from conceptualization to dissemination and the need for culturally sensitive evidence-based interventions for Hispanic/Latino autistic children. This project is being developed by a skilled and experienced team of investigators.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Roseann C Schaaf, PhD
- Phone Number: 6102912179
- Email: roseann.schaaf@jefferson.edu
Study Contact Backup
- Name: Lady J Rios- Vega, OTD
- Phone Number: 8568894683
- Email: lady.rios-vega@jeferson.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Autistic person:
- confirmed diagnosis of autism spectrum disorder
- Hispanic/Latino
- received therapeutic services as a child; and
- willing and able (with i.e., language and cognitive skills) to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.
Parent/caregiver:
- Hispanic/Latino caregiver of an autistic child who receives or received therapeutic services such as occupational, physical, speech and language therapy
- willing to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.
Exclusion Criteria:
- Do not meet age for autistic individual or diagnostic criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Design Thinking Group
A group of randomized participants (autistic adults, parents/caregivers, OT practitioners, teachers, and cultural experts) will participate in the Design Thinking (DT) process.
|
Participants attend the DT session through all the stages that include emphasize, define, ideate, prototype and test.
|
|
Other: Focus Group
A group of randomized participants (autistic adults, parents/caregivers, OT practitioners, teachers, and cultural experts) will participate in the Focus Group (FG) process.
|
Participants attend the FG that includes the introduction.
discussion, and reflection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stakeholder-Centric Engagement Evaluation
Time Frame: up to 14 weeks
|
The instrument evaluates stakeholder engagement via the PCORI engagement principles.
DT and FG participants use this instrument to rate engagement in throughout the research process using a Likert scale with 1= never and 5 = always.
|
up to 14 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and the Feasibility of Intervention Measure (FIM) (Weiner et al., 2017)
Time Frame: up to 14 weeks
|
These are outcome measures that evaluate implementation success via the extent to which stakeholders believe the intervention is acceptable, appropriate, and feasible.
Each measure uses a Likert response scale where 1 = completely disagree and 5 = completely agree.
|
up to 14 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Roseann C Schaaf, Thomas Jefferson University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022C2-28939
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Engagement
-
Cedars-Sinai Medical CenterTerminated
-
University of AarhusUnknownPatient Engagement | Patient Empowerment | Patient Compliance
-
University of WashingtonNational Institute of Mental Health (NIMH); Mental Health America; TalkspaceCompleted
-
Inonu UniversityCompleted
-
The Cleveland ClinicActive, not recruitingPatient EngagementUnited States
-
University of North Carolina, Chapel HillCompleted
-
NYU Langone HealthCompleted
-
University of California, San DiegoPatient-Centered Outcomes Research Institute; University of Massachusetts,... and other collaboratorsCompletedPatient Engagement | Physician-Patient Relations | Physician's Role | Patient ActivationUnited States
-
Medical College of WisconsinCompletedCommunication | Patient EngagementUnited States
-
Palo Alto Medical FoundationUniversity of Rochester; Dartmouth College; Gordon and Betty Moore Foundation; ... and other collaboratorsCompletedPatient Engagement | Physician's Role | Physician-Patient Relationship
Clinical Trials on Design Thinking
-
Chinese University of Hong KongCompleted
-
Virginia Polytechnic Institute and State UniversityNational Institute of Nursing Research (NINR); Carilion Clinic; University at...CompletedType 2 DiabetesUnited States
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI); Roswell Park Comprehensive Cancer CenterNot yet recruitingCigarette Smoking BehaviorUnited States
-
University of VermontWithdrawnTobacco Smoking
-
Henry Ford Health SystemMichigan State University; University of Kansas; University of Maryland, College...Recruiting
-
Virginia Polytechnic Institute and State UniversityCarilion Clinic; University at BuffaloCompletedType 2 Diabetes | Overweight and ObesityUnited States
-
Virginia Polytechnic Institute and State UniversityCarilion ClinicCompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
University of ConnecticutNational Institute of Nursing Research (NINR); University of Southern California and other collaboratorsCompleted
-
Henry Ford Health SystemUniversity of Kansas; University of Maryland, College ParkActive, not recruiting
-
Human Development Research Foundation, PakistanUniversity of Liverpool; Shifa Tameer-e-Millat UniversityCompletedDepression, Postpartum | Perinatal DepressionPakistan